Valsartan NDMA Videos

Valsartan is categorized as an “angiotensin II receptor blocker (ARB)”, a category of drug that has been the subject of enhanced scrutiny by the United States Food and Drug Administration (FDA) going back nearly a decade, long before concerns over NDMA contamination prompted recalls of generic valsartan in the summer of 2018. In a series of Drug Safety Communications dating back at least until 2010, the FDA reported that it was exploring potential links between ARBs like Valsartan and an increased risk of cancer.

TheLawFirm.com co-founder Jeremy Fietz gives detailed information on the drug valsartan and vaslartan's side effects and what you can do if you've been injured by this dangerous recalled drug. See our valsartan recall lawsuit page for more information about legal action against Valsartan.

Have you received a cancer diagnosis after taking the prescription drug Valsartan? If so, you need to speak with an experienced Valsartan lawsuit attorney. TheLawfirm.com drug recall lawyers are focused on one thing: providing compassionate and experienced legal representation to the victims of recalled drugs.